1-500 | 501-1000 | 1001-1102
     Part,  Chapter, Paragraph

   1    -,     1            |            process (from 15 November 2005 to November 2008), begun
   2    I,     2.  2        |        import and export) was 19% in 2005 (the same as in the USA
   3    I,     2.  4        |    economically developed (Eurostat, 2005). Even broader gaps can
   4    I,     2.  4        |            can be observed (APPLICA, 2005; Table 2.2).~ ~Table 2.2.
   5    I,     2.  4        |          Report prepared by APPLICA, 2005; Semenza and Giesecke, American
   6    I,     2.  4        |      presidency of the EU in October 2005, and other documents clearly
   7    I,     2.  5        |            in 1995 to 71 per cent in 2005 in developed countries.
   8    I,     2.  5        |             satisfaction (EUROFOUND, 2005). Key factors for workers’
   9    I,     2.  5        |           increase by almost 9% from 2005 to 2010, but the number
  10    I,     2.  5        |           Finnish Heart Association, 2005). These issues have a gender
  11    I,     2.  5        |            of the workforce (Ivanov, 2005). People living under long-term
  12    I,     2.  7        |         Marrone, 2007; Arcury et al, 2005).~ ~Human settlements have
  13    I,     2. 10.  3    |            In particular, the Europe 2005 Action Plan targeted a dynamic
  14    I,     2. 10.  3    |     regulatory reforms. The e-Europe 2005 Action Plan has now been
  15    I,     2. 10.  3    |           services.~ ~E-Contentplus (2005-2008) supports the development
  16    I,     2. 10.  4(10)|            la hospilitizacion (ENEAS 2005). Informe. Febrero 2006.
  17    I,     2. 10.  4    |        Customs, a 384% growth versus 2005(14). It is likely that counterfeiting
  18    I,     2. 10.  4    |       increase of more than 90% from 200515.~ ~The introduction of
  19    I,     2. 10.  4(18)|                        De Scioli D. (2005). Differatiating the Hospital
  20    I,     2. 11        |            11. References~ ~APPLICA (2005): Network on Social Inclusion
  21    I,     2. 11        |            Social Affairs). December 2005 [on-line publication available
  22    I,     2. 11        |              Spencer, J., Perin, J. (2005): The effects of geography
  23    I,     2. 11        |              conditions (EUROFOUND) (2005): High performance workplace
  24    I,     2. 11        |       Available at: htt ~ ~EUROSTAT (2005):. Regions: statistical
  25    I,     2. 11        |        Regions: statistical yearbook 2005. Data 1999-2003. [on-line
  26    I,     2. 11        |           Finnish Heart Association (2005): Action Plan for Promoting
  27    I,     2. 11        |           Heart Health for the Years 2005-2011. Helsinki, Finnish
  28    I,     2. 11        |              Oberdörster G. et al., (2005): Nanotoxicology: An emerging
  29    I,     2. 11        |              Tsolova S, Mortensen J (2005): The impact of health on
  30    I,     3.  1        |             States in 1960, 1980 and 2005 and the forecast for 2050~ ~
  31    I,     3.  1        |             everywhere in the EU. In 2005 Ireland (1.88) and France (
  32    I,     3.  1        |         fertility rates below 1.5 in 2005.~ ~The overall fertility
  33    I,     3.  1        |        cohort 1955, who turned 50 in 2005 (i.e. they are currently
  34    I,     3.  2        |               per 1,000 population), 2005~ ~The recent enlargement
  35    I,     3.  3        |             1963 (43 years of age in 2005). People born in later years
  36    I,     3.  3        |              21.6 in 1980 to 25.5 in 2005. The country specific trends
  37    I,     3.  3        |              on average from 25.9 in 2005 to 53.2 in 2050. This means
  38    I,     3.  3        |              States. Compared to the 2005 values, all ratios will
  39    I,     3.  3        |             annual growth rates from 2005 to 2049. Their old-age-dependency
  40    I,     3.  3        |          various age groups in 1975, 2005, 2010 and 2025, the following
  41   II,     4.  1        |             some drops over the 1980-2005 period. Here males had in
  42   II,     4.  1        |       Indicator on health and in its 2005 annual report to the Spring
  43   II,     4.  1        |            the European Communities, 2005).~ ~However, the significant
  44   II,     4.  1        |             expectancy estimates for 2005 were computed using the
  45   II,     4.  1        |            estimates for the EU25 in 2005 were computed with an algorithm
  46   II,     4.  1        |              Living Conditions (SILC 2005).~ ~SILC contains the Minimum
  47   II,     4.  1        |        activity limitation), are for 2005 and were collected or estimated
  48   II,     4.  1        |             for all Member States in 2005.~ ~Trends in DFLE for the
  49   II,     4.  1        |            LE estimates from 1995 to 2005 for the 27 current MS were
  50   II,     4.  1        |              for France and Italy in 2005 (see above).~ ~All health
  51   II,     4.  1        |              1.1 shows estimates for 2005 at European level (EU25)
  52   II,     4.  1        |            European Union (EU25), in 2005, per gender.~ ~The number
  53   II,     4.  1        |            Life Years (HLY) lived in 2005 by the inhabitants of the
  54   II,     4.  1        |            Table 4.1.1). Although in 2005 the EU life expectancy at
  55   II,     4.  1        |           Union (EU27), from 1995 to 2005, per gender~ ~Over the 10
  56   II,     4.  1        |              the 10 year period 1995-2005, life expectancy at birth
  57   II,     4.  1        |            European Union (EU25), in 2005, per gender~ ~Table 4.1.
  58   II,     4.  1        |         between the Member States in 2005. At MS level, values of
  59   II,     4.  1        |          life expectancy at birth in 2005 range from 65.3 years to
  60   II,     4.  1        |         between the Member States in 2005 at 50 and 65. Indeed at
  61   II,     4.  1        |             of the European Union in 2005 (EU25), for men and women,
  62   II,     4.  1        |          with Severe Limitations, in 2005, Men~ ~Figure 4.1.2. Life
  63   II,     4.  1        |          with Severe Limitations, in 2005, Women.~ ~ ~The calculation
  64   II,     4.  1        |              estimated by the HLY in 2005. Around 20% (19% for men
  65   II,     4.  1        |             of the older workers. In 2005 the gaps between the MS
  66   II,     4.  1        |            to the next (Robine et al 2005).~ ~One of the main criteria
  67   II,     4.  1        |             and Japan in 1995 and in 2005 and by gender. The US data
  68   II,     4.  1        |             and in Japan in 1995 and 2005, per gender~ ~Table 4.1.
  69   II,     4.  1        |              5 shows firstly that by 2005 LE at birth is almost identical
  70   II,     4.  1        |              the 10-year period 1995-2005 and the second largest (
  71   II,     4.  2        |           average change in the 2000-2005 period, the pattern is similar:
  72   II,     4.  2        |  Standardized death rates in EU27 in 2005~ ~Inequalities in life expectancy.
  73   II,     4.  3        |            the European Communities (2005): 2005 Commission Communication
  74   II,     4.  3        |         European Communities (2005): 2005 Commission Communication
  75   II,     4.  3        |             the Lisbon Strategy. COM(2005): 24.~ ~Jagger, C. and EHEMU
  76   II,     4.  3        |           Jagger, C. and EHEMU Team (2005): Healthy life expectancy
  77   II,     4.  3        |         Deaths: Preliminary Data for 2005, U.S. National Center for
  78   II,     4.  3        |       Abridged Life Tables for Japan 2005. Tokyo, Statistics and Information
  79   II,     4.  3        |               M., S. Le Roy, et al. (2005): Changes in life expectancy
  80   II,     5.  1.  1    |        compare to men (Parkin et al, 2005). Although male lung cancer
  81   II,     5.  2.  1    |            al, 2008; Petersen et al, 2005).~Even though clinical onset
  82   II,     5.  2.  4    |            in 1995-96, 1999-2000 and 2005-6 in different European
  83   II,     5.  2.  5    |       mortality decline (Unal et al, 2005).~The falling rates have
  84   II,     5.  2.  5    |             of life (Daviglus et al, 2005). It is commonly believed
  85   II,     5.  2.  5    |     Luxembourg Declaration29 June 2005), adopted under the Luxembourg
  86   II,     5.  2.  6    |          mortality (Baigent C et al, 2005). The available information,
  87   II,     5.  2.  6    |      Trialists' (CTT) Collaborators (2005). Efficacy and safety of
  88   II,     5.  2.  6    |             Maheshwari N, Schrott H (2005). Pleiotropic effects of
  89   II,     5.  2.  7    |              Wang R, Lubitz J et al (2005): Cardiovascular risk profile
  90   II,     5.  2.  7    |       Luengo-Fernandez R and Gray A (2005): European cardiovascular
  91   II,     5.  2.  7    |             JA, Fidan D, Capewell S (2005): Life-Years Gained from
  92   II,     5.  3.  2    |            Commission and started in 2005, involves Denmark, France,
  93   II,     5.  3.  2    |              MOSES-II, by the end of 2005, collected data from 34
  94   II,     5.  3.  4    |       compared to men (Parkin et al, 2005). Although male lung cancer
  95   II,     5.  3.  5    |      invasive cancers (Parkin et al, 2005). The screening effect on
  96   II,     5.  3.  5    |         entire Europe (Parkin et al, 2005). The risk of developing
  97   II,     5.  3.  6    |            In EUROCARE, Gatta et al (2005) analyzed survival in 129,
  98   II,     5.  3.  7    |             ESTONIA~Yes~IRELAND~Yes (2005)~GREECE~No~SPAIN~Yes (regional)~
  99   II,     5.  3.  9    |              EUROCARE Working Group (2005): Childhood Cancer Survival
 100   II,     5.  3.  9    |          Bray F, Ferlay J, Pisani P (2005): Global cancer statistics,
 101   II,     5.  4.  8    |         Orsini M, Massi Benedetti M (2005), Diabetes registers and
 102   II,     5.  4.  8    |           idf.org/EU_diabetes_report_2005]~(report online, accessed
 103   II,     5.  5.Int(10)|             McCollam A, Woodhouse A (2005): Equal minds. Scottish
 104   II,     5.  5.Int    |          Conclusions adopted in June 2005 reinforced this message
 105   II,     5.  5.Int    |             the implementation.~ ~In 2005, the European Commission
 106   II,     5.  5.  1    |              misuse (Sullivan et al, 2005), but is also associated
 107   II,     5.  5.  1    |       substance misuse (Mann et al., 2005). Major depression is found
 108   II,     5.  5.  1    |              death rate) in 1995 and 2005 in the EU. Source: Eurostat~ ~
 109   II,     5.  5.  1    |    depression in Sweden from 1997 to 2005. Eur Psychiatry 22(3):146-
 110   II,     5.  5.  1    |      Psychiatry 22(3):146-52.~ ~S G (2005). The prevalence and impact
 111   II,     5.  5.  2    |          carried out by Ferri et al (2005) on behalf of Alzheimer’
 112   II,     5.  5.  2    |             the statistics were from 2005. Those for the UK and Estonia
 113   II,     5.  5.  2    |             EURODEM and Ferri et al (2005) studies are as follows.
 114   II,     5.  5.  2    |             reported by Ferri et al (2005)~ ~Using these prevalence
 115   II,     5.  5.  2    |           member states from 1960 to 2005 (Alzheimer Europe, 2006a).
 116   II,     5.  5.  2    |           has increased from 1960 to 2005. This increase is linked
 117   II,     5.  5.  2    |              the period from 1960 to 2005, the number of people with
 118   II,     5.  5.  2    |         upward trend.~ ~Ferri et al (2005) made estimates of future
 119   II,     5.  5.  2    |            with them (Godfrey et al, 2005). It is becoming increasingly
 120   II,     5.  5.  2    |         inconclusive (Godfrey et al, 2005).~ ~Secondary Prevention~
 121   II,     5.  5.  2    |            Ferri CL, Prince M et al (2005): Global prevalence of dementia:
 122   II,     5.  5.  2    |               Boyle G and Brooker D (2005): Summary report for the
 123   II,     5.  5.  3    |       Adolescence (HELENA started in 2005, ends in 2008) aims at understanding
 124   II,     5.  5.  3    |          were published from 1980 to 2005 and explain the results
 125   II,     5.  5.  3    |        policy and intervention (WHO, 2005):~· provide accurate and
 126   II,     5.  5.  3    |        Related Eating Disorders Inc, 2005).~In the future, the European
 127   II,     5.  5.  3    |       Related Eating Disorders Inc. (2005): Eating disorders prevention:
 128   II,     5.  5.  3    |           Health Organization (WHO) (2005): The European Health Report
 129   II,     5.  5.  3    |           The European Health Report 2005Part 3 Child an adolescent
 130   II,     5.  5.  3    |       systematic review (Saha et al, 2005) of prevalence data evaluated
 131   II,     5.  5.  3    |        schizophrenia (Wrigley et al, 2005). The quality of psychiatric
 132   II,     5.  5.  3    |       support (Andlin-Sobocki et al, 2005).~Schizophrenia belongs
 133   II,     5.  5.  3    |             is derived from the year 2005), data from countries like
 134   II,     5.  5.  3    |          morbidity risk (Saha et al, 2005). These findings are reported
 135   II,     5.  5.  3    |        illness onset” (Palmer et al, 2005), a comparison of suicide
 136   II,     5.  5.  3    |    Disability adjusted life-years~In 2005, neuropsychiatric conditions
 137   II,     5.  5.  3    |            data of 2002 for the year 2005: In the WHO European Region
 138   II,     5.  5.  3    |              medication (Holt et al, 2005).~A great deal of co-morbid
 139   II,     5.  5.  3    |     psychosis. (Klosterkötter et al, 2005; Klosterkötter, 2007).~The
 140   II,     5.  5.  3    |              al, 2006; Gaebel et al, 2005; AGREE Collaboration, 2003) –
 141   II,     5.  5.  3    |              distance (Gaebel et al, 2005).~Direct and indirect costs
 142   II,     5.  5.  3    |            Andlin-Sobocki & Rössler, 2005).~In 2004, the costs for
 143   II,     5.  5.  3    |          paper (European Commission, 2005) and the WHO Helsinki Declaration (
 144   II,     5.  5.  3    |      European Ministerial Conference 2005~www. Mental health promotion
 145   II,     5.  5.  3    |           backgrounds (Gaebel et al, 2005). Another solution, as suggested
 146   II,     5.  5.  3    |   Interventions and Policy Options” (2005) mentions 7 groups of disorders
 147   II,     5.  5.  3    |               Wittchen HU, Olesen J (2005): Cost of disorders of the
 148   II,     5.  5.  3    |       Andlin-Sobocki P, & Rössler W (2005):Cost of psychotic disorders
 149   II,     5.  5.  3    |            206.~European Commission (2005): Green Paper. Improving
 150   II,     5.  5.  3    |              N, Rutz W, McIntyre JS (2005): Schizophrenia practice
 151   II,     5.  5.  3    |              RI, Bushe C, Citrome L (2005): Diabetes and schizophrenia
 152   II,     5.  5.  3    |           Diabetes and schizophrenia 2005: are we any closer to understanding
 153   II,     5.  5.  3    |        Hambrecht M, VON Reventlow H (2005): The European Prediction
 154   II,     5.  5.  3    |            Pankratz VS, Bostwick JM (2005): The lifetime risk of suicide
 155   II,     5.  5.  3    |          Saha S, Chant D, McGrath J (2005): A systematic review of
 156   II,     5.  5.  3    |              in the Nordic Countries 2005 - Mental health in the Nordic
 157   II,     5.  5.  3    |        Copenhagen, Helsinki 10. Jan. 2005. Available at: htt 1; last
 158   II,     5.  5.  3    |         Jackson H, Judd F, Komiti A (2005): Role of stigma and attitudes
 159   II,     5.  5.  3    |              among others (Fombonne, 2005).~ ~It is not possible to
 160   II,     5.  5.  3    |              autism in the UK.~Since 2005, ASD has been included in
 161   II,     5.  5.  3    |        Reports, Nov-Dec.~Fombonne E (2005): Epidemiology of autistic
 162   II,     5.  5.  3    |       Journal of Clinical Psychiatry 2005, 66 (suppl. 10)~Knapp M,
 163   II,     5.  5.  3    |           conducted (Forsgren et al, 2005). In these studies, the
 164   II,     5.  5.  3    |             100,000 (Forsgren et al, 2005; Olafsson et al, 2005).
 165   II,     5.  5.  3    |            al, 2005; Olafsson et al, 2005). The incidence is higher
 166   II,     5.  5.  3    |              to 56% (Forsgren et al, 2005). The differences are mostly
 167   II,     5.  5.  3    |             Iceland (Olafsson et al, 2005), the incidence of single
 168   II,     5.  5.  3    |              Europe (Forsgren et al, 2005). The overall prevalence
 169   II,     5.  5.  3    |            2004 and Forsgren et al., 2005~ ~Country ~Population ~Design~
 170   II,     5.  5.  3    |              2001(*)/Gallitto et al, 2005~Italy ~Children ~MR review~? ~
 171   II,     5.  5.  3    |       perspective (Beghi and Sander, 2005). From a patient’s perspective,
 172   II,     5.  5.  3    |             rate ratio, RR 1.8)(Vaa, 2005) and the risk of serious
 173   II,     5.  5.  3    |           across Europe. On April 27 2005, the SEWGED submitted a
 174   II,     5.  5.  3    |              63.~Beghi E, Sander JW (2005): Epilepsy and driving.
 175   II,     5.  5.  3    |         Beghi E, Oun A, Sillanpaa M (2005): The epidemiology of epilepsy
 176   II,     5.  5.  3    |          Serra S, La Spina P, et al (2005): Prevalence and characteristics
 177   II,     5.  5.  3    |             P, Gudmundsson G, et al (2005): Incidence of unprovoked
 178   II,     5.  5.  3    |         Epilepsy Res 60:1-16.~Vaa T (2005): Impairments, diseases,
 179   II,     5.  5.  3    |                      accessed 10 May 2005).~Van den Broek M, Beghi
 180   II,     5.  5.  3    |         Society (Flachenecker et al, 2005; www ). This project aimed
 181   II,     5.  5.  3    |           annual cost per patient in 2005, total direct costs (healthcare
 182   II,     5.  5.  3    |            burden of MS for the year 2005 was €13 billion, i.e., €
 183   II,     5.  5.  3    |        dominate with €2.5 billion in 2005 (41% of direct costs or
 184   II,     5.  5.  3    |           cost of MS in Europe (year 2005) by resource use components.~ ~
 185   II,     5.  5.  3    |          Code was drawn up in spring 2005 as follow up to the above
 186   II,     5.  5.  3    |           Zettl UK , Götze U, et al (2005): [MS registry in Germany—
 187   II,     5.  5.  3    |       results of the extension phase 2005/2006. Poster presentation
 188   II,     5.  5.  3    |            138.~Global Health Atlas (2005). Available at: htt rg Accessed
 189   II,     5.  5.  3    |                     Accessed June 14 2005.~Granieri E, Malagú S, Casetta
 190   II,     5.  5.  3    |           Riise T, Sotgiu MA, et al (2005): Increasing incidence of
 191   II,     5.  5.  3    |              von Campenhausen et al, 2005). It mainly affects voluntary
 192   II,     5.  5.  3    |            respectively (Nath et al, 2005; Orphanet, 2007; Vanacore,
 193   II,     5.  5.  3    |            Orphanet, 2007; Vanacore, 2005).~Although, the disease
 194   II,     5.  5.  3    |         Committee, 2002; Hely et al, 2005).~PD mainly affects older
 195   II,     5.  5.  3    |        Europe (Andlin-Sobocki et al, 2005).~
 196   II,     5.  5.  3    |     available (Andlin-Sobocki et al, 2005; Dowding et al, 2006; Lindgren
 197   II,     5.  5.  3    |            al, 2006; Lindgren et al, 2005; von Campenhausen et al,
 198   II,     5.  5.  3    |              von Campenhausen et al, 2005).~ ~ ~ ~
 199   II,     5.  5.  3    |              von Campenhausen et al, 2005).~ ~Table 5.5.3.6.2. Prevalence
 200   II,     5.  5.  3    |             al, 2003; Spottke et al, 2005). A generally accepted way
 201   II,     5.  5.  3    |            is about 1.8 (Hely et al, 2005; Hely et al, 1999). The
 202   II,     5.  5.  3    |                Andlin-Sobocki et al, 2005). The cost per case differed
 203   II,     5.  5.  3    |            al, 1999; Lindgren et al, 2005; McCrone et al, 2007; Spottke
 204   II,     5.  5.  3    |             al, 2007; Spottke et al, 2005). Direct cost only reflect
 205   II,     5.  5.  3    |             al, 1999; Spottke et al, 2005). Nevertheless, also a decrease
 206   II,     5.  5.  3    |         study (Andlin-Sobocki et al, 2005) also demonstrate that the
 207   II,     5.  5.  3    |             et al, 2002; Logroscino, 2005; Tanner, 2003; Tanner and
 208   II,     5.  5.  3    |        Europe (Andlin-Sobocki et al, 2005). Parkinson’s disease has
 209   II,     5.  5.  3    |            most populous nations: in 2005, the number of individuals
 210   II,     5.  5.  3    |               Wittchen HU, Olesen J (2005): Cost of disorders of the
 211   II,     5.  5.  3    |           the most populous nations, 2005 through 2030. Neurology
 212   II,     5.  5.  3    |              Reid WG, Trafficante R (2005): Sydney Multicenter Study
 213   II,     5.  5.  3    |       Spottke E, Siebert U, Dodel R (2005): Cost of Parkinson’s disease
 214   II,     5.  5.  3    |         Suppl 1:68-73.~Logroscino G (2005): The role of early life
 215   II,     5.  5.  3    |            Lees A, Rooney C, Burn D (2005): Population based mortality
 216   II,     5.  5.  3    |           Oertel WH, Ulm G, Dodel R (2005): Cost of illness and its
 217   II,     5.  5.  3    |              6):549-554.~Vanacore N (2005): Epidemiological evidence
 218   II,     5.  5.  3    |        Siebert U, Berger K, Dodel R (2005): Prevalence and incidence
 219   II,     5.  6.  2    |          Bone and Joint Decade, Lund 2005 (European Commission (2004):
 220   II,     5.  6.  2    |         Current Osteoporosis Reports 2005; 3: 84-91 (Woolf and Pfleger,
 221   II,     5.  6.  2    |            84-91 (Woolf and Pfleger, 2005)~ ~The content of this chapter
 222   II,     5.  6.  3    |              years (Hulsemann et al, 2005). These costs are strongly
 223   II,     5.  6.  3    |          over 50 (Kanis and Johnell, 2005).~ ~Most distal forearm
 224   II,     5.  6.  6    |   Schulenburg JM, Zeidler H, Ruof J (2005): Direct Costs Related to
 225   II,     5.  6.  6    |              Kanis JA and Johnell O (2005): Requirements for DXA for
 226   II,     5.  6.  6    |              95~Woolf AD, Pfleger B (2005): Burden of osteoporosis
 227   II,     5.  7.  1    |           exhibit CKD (Coresh et al, 2005 ). Estimates in Asia and
 228   II,     5.  7.  1    |           and Australia (Chen et al, 2005; Chadban et al, 2003) indicate
 229   II,     5.  7.  1    |     completed (Viktorsdottir et al., 2005; Otero et al., 2005; de
 230   II,     5.  7.  1    |             al., 2005; Otero et al., 2005; de Zeeuw D et al., 2005;
 231   II,     5.  7.  1    |             2005; de Zeeuw D et al., 2005; Hallan et al. 2006a; Hallan
 232   II,     5.  7.  1    |              chronic diseases in the 2005 WHO report (World Health
 233   II,     5.  7.  1    |           World Health Organization, 2005; Yach et al, 2004). However,
 234   II,     5.  7.  1    |              2003; Gansevoort et al, 2005) may be useful for the screening
 235   II,     5.  7.  1    |          adults (Gorodetskaya et al, 2005; Kimmel and Patel, 2006)
 236   II,     5.  7.  1    |              U.S. Renal Data System, 2005).~ ~Definitions~ ~Whenever
 237   II,     5.  7.  2    |             RRT over the period 1992-2005 are incomplete. Seven EU-15
 238   II,     5.  7.  3    |           Esbjorner et al, 1997). In 2005 the incidence rate of RRT
 239   II,     5.  7.  3    |     difficulties (Winkelmayer et al, 2005). No data has been published
 240   II,     5.  7.  3    |              x years (Kurella et al, 2005). Similarly scarce are the
 241   II,     5.  7.  3    |            NHANES data (Coresh et al,2005).~ ~In Europe similar data
 242   II,     5.  7.  3    |           obesity and diabetes.~ ~In 2005 the incidence rates of RRT
 243   II,     5.  7.  3    |              rate of RRT for ESRD in 2005 steeply increased with age
 244   II,     5.  7.  3    |          rates in Canada (160 pmp in 2005) are similar to those in
 245   II,     5.  7.  3    |             in US whites (286 pmp in 2005) (U.S. Renal Data System,
 246   II,     5.  7.  3    |       Incidence of RRT over the 1992-2005 period per age group, gender
 247   II,     5.  7.  3    |       Incidence of RRT over the 1992-2005 period per country~ ~Table
 248   II,     5.  7.  3    |       Incidence of RRT over the 2000-2005 period per country.~ ~Trends
 249   II,     5.  7.  3    |   adolescents or adults.~In the 1992-2005 period the incidence rate
 250   II,     5.  7.  3    |            al, 2003; van Dijk et al, 2005) After 2002, the incidence
 251   II,     5.  7.  3    |             Heijden et al, 2004). In 2005 the prevalence of RRT in
 252   II,     5.  7.  3    |         Netherlands (De Zeeuw et al, 2005) and in Spain (Garcia-Lopez
 253   II,     5.  7.  3    |       Iceland) (Viktorsdottir et al, 2005) in females (Figure 5.7.
 254   II,     5.  7.  3    |        Iceland (Viktorsdottir et al, 2005), Norway (Hallan et al,
 255   II,     5.  7.  3    |         disease by age and sex.~ ~In 2005 the crude prevalence of
 256   II,     5.  7.  3    |             RRT over the period 1992-2005 by country.~ ~Table 5.7.
 257   II,     5.  7.  3    |             RRT over the period 2000-2005 by country.~ ~Table 5.7.
 258   II,     5.  7.  3    |             RRT over the period 1992-2005 by age group, gender and
 259   II,     5.  7.  3    |          Europe over the period 1992-2005 (Table 5.7.7) the overall
 260   II,     5.  7.  3    |             2007; ERA-EDTA Registry, 2005). Also within Europe there
 261   II,     5.  7.  3    |            al, 2003; van Dijk et al, 2005) After 2002 the incidence
 262   II,     5.  7.  5    |          provided (Gansevoort et al, 2005) . Patients with neoplasia
 263   II,     5.  7.  5    |             dialysis patients. Since 2005, it has been mandatory for
 264   II,     5.  7.  7    |           S1-S85.~Annual data report 2005., Bethesda, MD: United States
 265   II,     5.  7.  7    |       Digestive and Kidney Diseases; 2005.~Ardissino G, Dacco V, Testa
 266   II,     5.  7.  7    |        Spruill M, Reynolds K, et al (2005) Prevalence of decreased
 267   II,     5.  7.  7    |              to 74 years. Kidney Int 2005;68(6):2839-45.~Chobanian
 268   II,     5.  7.  7    |         Eggers PW, Lacher DA, et al (2005): Chronic kidney disease
 269   II,     5.  7.  7    |            to 2000. J Am Soc Nephrol 2005 Jan;16(1):180-8.~de Zeeuw
 270   II,     5.  7.  7    |              Hillege HL, de Jong PE (2005): The kidney, a cardiovascular
 271   II,     5.  7.  7    |            therapy. Kidney Int Suppl 2005 Sep;(98):S25-S29.~Diez Roux
 272   II,     5.  7.  7    |              702.~ERA-EDTA Registry (2005): 2005 Annual Report. Academic
 273   II,     5.  7.  7    |            ERA-EDTA Registry (2005): 2005 Annual Report. Academic
 274   II,     5.  7.  7    |          Bakker SJ, de Zeeuw, et al (2005): The validity of screening
 275   II,     5.  7.  7    |         population. Kidney Int Suppl 2005 Apr;(94):S28-S35.~Garcia-Lopez
 276   II,     5.  7.  7    |           Hsu CY, Bindman AB, et al (2005): Health-related quality
 277   II,     5.  7.  7    |           kidney disease. Kidney Int 2005 Dec;68(6):2801-8.~Hallan
 278   II,     5.  7.  7    |        Kurella M, Lo JC, Chertow GM (2005): Metabolic syndrome and
 279   II,     5.  7.  7    |             adults. J Am Soc Nephrol 2005 Jul;16(7):2134-40.~Levey
 280   II,     5.  7.  7    |           Garcia F, de Francisco AL (2005): Epidemiology of chronic
 281   II,     5.  7.  7    |              study. Kidney Int Suppl 2005 Dec;(99):S16-S19.~Pontoriero
 282   II,     5.  8.  3    |            study by Lindberg et al. (2005), in a symptomatic cohort
 283   II,     5.  8.  3    |          study by Johannessen et al (2005) reported cumulative incidence
 284   II,     5.  8.  3    |             3% COPD) (Murtagh et al, 2005).~ ~The WHO’s Large Analysis
 285   II,     5.  8.  3    |             2025 (Hoogendoorn et al, 2005). As regards the measurement
 286   II,     5.  8.  3    |             COPD (Hoogendoorn et al, 2005) in males and 3..9, 8.1,
 287   II,     5.  8.  3    |    health-care system (Sidney et al, 2005). These were diabetes, hypertension,
 288   II,     5.  8.  3    |              study by Soriano et al (2005), the UK General Practice
 289   II,     5.  8.  4    |              al, 2001; Sunyer et al, 2005).~ ~The exact prevalence
 290   II,     5.  8.  7    |              Lammers JW, Verheij TJ (2005): Prevalence of undetected
 291   II,     5.  8.  7    |              65 years old. Fam Pract 2005; 22: 485-489.~ ~Goodridge
 292   II,     5.  8.  7    |       Omenaas E, Bakke P, Gulsvik A (2005): Incidence of GOLD-defined
 293   II,     5.  8.  7    |    population. Int J Tuberc Lung Dis 2005; 9: 926-932.~ ~Jorgensen
 294   II,     5.  8.  7    |              Larsson LG, Lundback B (2005): Ten-year cumulative incidence
 295   II,     5.  8.  7    |            symptomatic cohort. Chest 2005; 127: 1544-1552.~ ~Lindberg
 296   II,     5.  8.  7    |             Patterson C, MacMahon J (2005): Prevalence of obstructive
 297   II,     5.  8.  7    |      NICECOPD study. Eur J Epidemiol 2005; 20: 443-453.~Niederlander
 298   II,     5.  8.  7    |          Medical Care Program. Chest 2005; 128: 2068-2075.~ ~Soriano
 299   II,     5.  8.  7    |              Payvandi N, Hansell AL (2005): Patterns of comorbidities
 300   II,     5.  8.  7    |        asthma in primary care. Chest 2005; 128: 2099-2107.~ ~Soriano
 301   II,     5.  8.  7    |           Respiratory Health Survey (2005): Lung Function Decline,
 302   II,     5.  9.  2    |              collected at the end of 2005.~ ~In early 1990s two large
 303   II,     5.  9.  3    |               ISAYA) (Bugiani et al, 2005), the prevalence of allergic
 304   II,     5.  9.  3    |            decreased from 1995 until 2005 (-52%) (Tuberkulóza a respirační
 305   II,     5.  9.  3    |      Tuberkulóza a respirační nemoci 2005; htt ). All these data underline
 306   II,     5.  9.  4    |            Custovic, 2003; Simpson , 2005; Erwin, 2005). Exposure
 307   II,     5.  9.  4    |               Simpson , 2005; Erwin, 2005). Exposure to house dust
 308   II,     5.  9.  4    |              pet ownership (Fasce L, 2005), but may also be in part
 309   II,     5.  9.  7    |              37, 788–79~ ~Bugiani M (2005): Allergic rhinitis and
 310   II,     5.  9.  7    |             adults in Italy. Allergy 2005, 60:165-170~ ~Burney PGJ (
 311   II,     5.  9.  7    |        Woodfolk JA, Platts-Mills TA (2005): Asthma and indoor air:
 312   II,     5.  9.  7    |           and dust-mite. Indoor Air. 2005;15 Suppl 10:33-9.~ ~European
 313   II,     5.  9.  7    |               Pistorio A, Rossi GA. (2005): “Earlycat ownership
 314   II,     5.  9.  7    |               Ann All Asthma Immunol 2005;94:561-565.~ ~Global Initiative
 315   II,     5.  9.  7    |              C, Svanec C, Kunzly N, (2005): Change in prevalence of
 316   II,     5.  9.  7    |            with age and cohort. JACI 2005;116:675-682).~ ~Keil T (
 317   II,     5.  9.  7    |             Curr Allergy Asthma Rep. 2005 May; 5(3):212-20.~ ~S P (
 318   II,     5. 10.  3    |          Source: Fasano and Catassi (2005)~ ~ ~ ~
 319   II,     5. 10.  5    |        implemented as of 25 November 2005. It is of renowned that
 320   II,     5. 10.  5    |       expressed as SO2 .~ ~Directive 2005/26/EC~- Lupin and products
 321   II,     5. 10.  5    |     substances. Commission Directive 2005/26/EC establishing a list
 322   II,     5. 10.  5    |             Commission on 21st March 2005, following the opinions
 323   II,     5. 10.  7    |                 European Commission (2005): Commission Directive 2005/
 324   II,     5. 10.  7    |          2005): Commission Directive 2005/26/EC of 21 March 2005 establishing
 325   II,     5. 10.  7    |     Directive 2005/26/EC of 21 March 2005 establishing a list of food
 326   II,     5. 10.  7    |           European Union L 75, 22.03.2005, pp. 3334.~htt ~ ~European
 327   II,     5. 10.  7    |             R, Booth IW, McDonald A (2005): Consequences of perceived
 328   II,     5. 11.  3    |               C Lidén and K Norberg, 2005). In a study published in
 329   II,     5. 11.  3    |              different. In Italy, in 2005, the percentage of subjects
 330   II,     5. 11.  3    |           same level (T Hasan et al. 2005).~ ~ ~From an experimental
 331   II,     5. 11.  3    |           study, Contact Dermatitis, 2005;53:4045.~CS Jensen, S Lisby,
 332   II,     5. 11.  3    |       Directive, Contact Dermatitis, 2005;52:2935.~L Matt o, Prevalence
 333   II,     5. 11.  3    |           and Germany (Fouere et al, 2005). The disease afflicts men
 334   II,     5. 11.  7    |         Fouere S, Adjadj L, Pawin H (2005): How patients experience
 335   II,     5. 11.  7    |           Eur Acad Dermatol Venereol 2005;19(S3):2-6.~ ~Gudjonsson
 336   II,     5. 11.  7    |            2007;25:535-546.~ ~Hay R (2005): Literature review. Onychomycosis.
 337   II,     5. 11.  7    |              Acad Dermatol Venereol. 2005;19 (S1):1-7.~ ~Herd RM,
 338   II,     5. 12.  2    |           National Cancer Institute, 2005).~Alcohol consumption data (
 339   II,     5. 12.  3    |         countries (de la Pena et al, 2005; Ioannou et al, 2003; Poynard
 340   II,     5. 12.  5    |         Margolis, 1990; Stroffolini, 2005). In the absence of a vaccine,
 341   II,     5. 12.  5    |             al, 2004; Shepard et al, 2005).~ ~ ~ ~Secondary prevention
 342   II,     5. 12.  7    |           National Cancer Institute (2005): Joinpoint Regression Program,
 343   II,     5. 12.  7    |             CW, Finelli L, Alter MJ (2005): Global epidemiology of
 344   II,     5. 12.  7    |            558-567.~ ~Stroffolini T (2005): The changing pattern of
 345   II,     5. 13        |            the European Communities, 2005; WHO, 2000). A body mass
 346   II,     5. 13        |          Regional Office for Europe, 2005).~ ~Lifestyle factors, including
 347   II,     5. 13        |            the European Communities, 2005). In 2002, the total direct
 348   II,     5. 13        |            per year (Fry and Finley, 2005). The WHO Regional Office
 349   II,     5. 14.  2    |             factors (Petersen et al, 2005). Few countries in Western
 350   II,     5. 14.  5    |             burdens (Petersen et al, 2005). Increasingly European
 351   II,     5. 14.  5    |               Petersen and Yamamoto, 2005). An EU oral health strategy
 352   II,     5. 14.  8    |              D, Bratthal D, Ogawa H (2005): Oral health information
 353   II,     5. 14.  8    |             Bull World Health Organ. 2005; 83: 686-693.~Petersen PE,
 354   II,     5. 14.  8    |          Estupinan-Day S, NDiaye C (2005): The global burden of oral
 355   II,     5. 14.  8    |             Bull World Health Organ. 2005; 83: 661-669.~Petersen PE,
 356   II,     5. 14.  8    |             Petersen PE, Yamamoto T (2005): Improving the oral health
 357   II,     5. 14.  8    |        Community Dent Oral Epidemiol 2005; 33: 8192.~Selwitz RH,
 358   II,     5. 15.  1    |        health authorities (Eurordis, 2005).~ ~
 359   II,     5. 15.  2    |         unknown aetiology (Orphanet, 2005). The definition of what
 360   II,     5. 15.  3    |          2006; Clarke, 2006; McCabe, 2005). Currently over 40 new
 361   II,     5. 15.  4    |           languages in June 2001. In 2005, Member States were asked
 362   II,     5. 15.  4    |          incentives as of the end of 2005.~ ~In 2000, a Committee
 363   II,     5. 15.  6    |         Medicinal Products, Revision 2005. Available at: htt , (accessed
 364   II,     5. 15.  6    |       accessed 12.05.2007)~Eurordis (2005): Rare diseases: understanding
 365   II,     5. 15.  6    |               Claxton K, Tsuchiya A (2005): Orphan drugs and the NHS:
 366   II,     5. 15.  6    |         should we value rarity? BMJ. 2005 Oct 29;331(7523):1016-9.~
 367   II,     6.  1        |             communicable diseases in 2005 in the 25 EU countries and
 368   II,     6.  2        |           official data for the year 2005 reported by the countries,
 369   II,     6.  3.  1    |              of general trends (19952005), EU incidence (2005), main
 370   II,     6.  3.  1    |            1995–2005), EU incidence (2005), main age groups affected (
 371   II,     6.  3.  1    |            main age groups affected (2005), and major threats detected (
 372   II,     6.  3.  1    |              major threats detected (2005) for diseases reported on
 373   II,     6.  3.  3    |          with HIV/AIDS at the end of 2005 and that about 15 000 individuals
 374   II,     6.  3.  3    |       countries.~ ~Risk factors~ ~In 2005, 28 044 HIV diagnoses were
 375   II,     6.  3.  3    |       generally continued throughout 2005, i.e. a rise in diagnoses
 376   II,     6.  3.  3    |           With 171 cases reported in 2005, mother-to-child transmission
 377   II,     6.  3.  3    |            shows a stable trend). In 2005, 203 691 cases of Chlamydia
 378   II,     6.  3.  3    |          since then (figure 6.3). In 2005, a total of 27 537 cases
 379   II,     6.  3.  3    |         overall decreasing trend. In 2005, 12 945 syphilis cases were
 380   II,     6.  3.  3    |              6 977 cases reported in 2005 by 26 countries, the highest
 381   II,     6.  3.  3    |            surveillance artefact. In 2005, more than 29 000 hepatitis
 382   II,     6.  3.  4    |            strain of the 200405 and 200506 winter seasons was mainly
 383   II,     6.  3.  4    |       pandemic was a main concern in 2005. Starting in late summer,
 384   II,     6.  3.  4    |            domestic poultry.~ ~Since 2005 there has been an extraordinary
 385   II,     6.  3.  4    |       substantially between 2001 and 2005, largely as a result of
 386   II,     6.  3.  4    |        Figure 6.A1.3 Combined MDR in 2005~ ~ ~ ~ ~Figure 6.A1.4 New
 387   II,     6.  3.  4    |          drug resistance low.~ ~ ~In 2005, the 25 EU countries plus
 388   II,     6.  3.  4    |              per 100 000 per year in 2005) and will effectively increase
 389   II,     6.  3.  4    |            important.~ ~In the EU in 2005, 22% of AIDS cases had TB
 390   II,     6.  3.  4    |            and 3.5%, respectively in 2005.~ ~Control tools and policies~ ~
 391   II,     6.  3.  4    |             per 100 000 per year. In 2005, a total of 4 189 human
 392   II,     6.  3.  4    |             per 100 000 per year. In 2005, 746 cases of travel-associated
 393   II,     6.  3.  4    |  Legionnairesdisease with onset in 2005 were reported to the EWGLINET
 394   II,     6.  3.  4    |           also appeared in Europe in 2005, the EU was largely spared
 395   II,     6.  3.  4    |             reported in the world in 2005.~Today, the most likely
 396   II,     6.  3.  5    |              the UK (increasing). In 2005, a total of 19 665 invasive
 397   II,     6.  3.  5    |      introduction of the vaccine. In 2005, a total of 5 494 cases
 398   II,     6.  3.  5    |               Ireland and the UK. In 2005, 1 145 cases were reported
 399   II,     6.  3.  5    |            groups (014 years).~ ~In 2005, a total of 13 207 cases
 400   II,     6.  3.  5    |            observed sporadically. In 2005, only Latvia reported cases (
 401   II,     6.  3.  5    |              in 2002 (two cases). In 2005, altogether 137 cases were
 402   II,     6.  3.  5    |            per year since 2000.~ ~In 2005, a total of 1 291 cases
 403   II,     6.  3.  5    |          vaccine.~ ~Between 1996 and 2005, there was a generally decreasing
 404   II,     6.  3.  5    |         Spain in 1996 and 2000.~ ~In 2005, a total of 52 918 cases
 405   II,     6.  3.  5    |           1996 and Spain in 1996.~In 2005, a total of 1 498 cases
 406   II,     6.  3.  6    |             between 1995 - 2004~ ~In 2005, more than 200 000 cases
 407   II,     6.  3.  6    |             parts of the world.~ ~In 2005, a total of 181 876 human
 408   II,     6.  3.  6    |           and 2004 (6 440 cases). In 2005, a total of 1 364 human
 409   II,     6.  3.  6    |              slight peak in 2001. In 2005, a total of 7 425 human
 410   II,     6.  3.  6    |       appears to be 04 year one. In 2005, a total of 5 218 cases
 411   II,     6.  3.  6    |          outbreaks were monitored in 2005, with beef, lettuce and
 412   II,     6.  3.  6    |            seen in 1998 and 2002. In 2005, 23 countries notified a
 413   II,     6.  3.  6    |              reported 1 491 cases in 2005. Denmark (0.85 per 100 000),
 414   II,     6.  3.  6    |             over 65 years of age. In 2005, 96 listeriosis cases were
 415   II,     6.  3.  6    |              reported 1 429 cases in 2005, with an overall incidence
 416   II,     6.  3.  6    |          over the 10-year period. In 2005, a total of 152 cases were
 417   II,     6.  3.  6    |            per 100 000 per year). In 2005, 34 cases were reported
 418   II,     6.  3.  6    |       remained stable since then. In 2005, 6 695 cases were reported
 419   II,     6.  3.  6    |      decreasing trend since then. In 2005, 1 519 toxoplasmosis cases
 420   II,     6.  3.  6    |           over the last 10 years. In 2005, some 15 103 cases were
 421   II,     6.  3.  6    |            trend data are scanty. In 2005, almost 8 000 cases were
 422   II,     6.  3.  6    |            decreasing since 1996. In 2005, altogether 337 cases were
 423   II,     6.  3.  6    |           been relatively stable. In 2005, 153 cases were reported
 424   II,     6.  3.  6    |      declined steadily until 2004~In 2005, a total of 21 cases were
 425   II,     6.  3.  7    |          although more in Sweden. In 2005, 508 cases were reported
 426   II,     6.  3.  7    |           every third year. The year 2005 saw one of these peaks,
 427   II,     6.  3.  7    |              5 cases per 100 000. In 2005, 958 cases were reported
 428   II,     6.  3.  7    |             overseas departments. In 2005, 900 cases were reported
 429   II,     6.  3.  7    |         followed by Greece (14%). In 2005, 21 countries reported just
 430   II,     6.  3.  7    |              EU (total 21 cases). In 2005, five cases of rabies were
 431   II,     6.  3.  7    |        Malaria trends in Europe~ ~In 2005, 4 306 malaria cases were
 432   II,     6.  3.  7    |            identified as a threat in 2005, are discussed here below.
 433   II,     6.  3.  7    |              of DHF were reported in 2005.~ ~Lassa fever is endemic
 434   II,     6.  3.  7    |            No cases were reported in 2005.~ ~Crimean-Congo haemorrhagic
 435   II,     6.  3.  7    |            No cases were reported in 2005.~ ~Ebola and Marburg haemorrhagic
 436   II,     6.  3.  7    |             the UK in 1998, 2001 and 2005, and two cases from Ireland
 437   II,     6.  4.  3    |              Commission organised in 2005 two scenario exercises (
 438   II,     6.  4.  4    |      inaugurated in Stockholm in May 2005.~ ~In accordance with its
 439   II,     7.  1        |           and safety promotion:~ ~In 2005 the WHO has passed a Regional
 440   II,     7.  3        |            Statistics summary 20032005” (see KfV, 2007)1. See also
 441   II,     7.  3        |           mostly for the period 2003-2005.~ ~
 442   II,     7.  3.  2    |            the EU. Based on the 2003-2005 figures for all ages, Lithuania
 443   II,     7.  3.  3    |              to injuries, EU27, 2003-2005~ ~On average about 1 500
 444   II,     7.  4.  2    |              a factor of two between 2005 and 2050, a significant
 445   II,     7.  4.  3    |       provided by Avenso & Beckmann, 2005.~ ~In the field of road
 446   II,     7.  4.  4    |           time of injury, EU27, 2003-2005~ ~The “sport injuriespriority
 447   II,     7.  4.  4    |            injury by age group, 2003-2005~ ~Physical exercise contributes
 448   II,     7.  4.  6    |   Organization, 2005c).~ ~In October 2005, the European Commission
 449   II,     7.  7        |               3 year average of 2003-2005. [https://webgate.ec.europa.
 450   II,     7.  7        |            European Injury Database (2005): Home and leisure accidents
 451   II,     7.  7        |              Statistics Summary 2003-2005. Vienna: Austrian Road Safety
 452   II,     7.  7        |             RC55/R9 of September 15, 2005. Copenhagen, WHO Regional
 453   II,     8.  1.  5    |             of the Action Plan (2004-2005) addressed the establishment
 454   II,     8.  1.  5    |    priorities for action during 2004-2005. The second phase of the
 455   II,     8.  1.  5(6) |                                  COM(2005)604 http df~
 456   II,     8.  2.  1    |       disparities (Scheepers et al., 2005). The European Union Health
 457   II,     8.  2.  1    |     conducted over two decades (1986-2005), with the majority (60%)
 458   II,     8.  2.  1    |             example (Ouellette-Kuntz 2005). Among people with intellectual
 459   II,     8.  2.  1    |        disabilities (Scheepers et al 2005) are among the factors likely
 460   II,     8.  2.  1    |   accommodation in England, Emerson (2005) found significant deviations
 461   II,     8.  2.  1    |             disabled people (Lennox, 2005). Pending approval, the
 462   II,     8.  2.  1    |  disabilities (Scheepers, Kerr et al 2005). At European Community
 463   II,     8.  2.  1    |          expectancy increases (Walsh 2005). Reflecting social policies
 464   II,     8.  2.  1    |                667–677.~Emerson, E. (2005) Underweight, obesity and
 465   II,     8.  2.  1    |            and Rutkowski-Kmitta, V. (2005). Disability Statistics
 466   II,     8.  2.  1    |            Developmental Disability (2005) Melbourne, Australia: Therapeutic
 467   II,     8.  2.  1    |             90~Ouellette-Kuntz, H., (2005). Understanding Health Disparities
 468   II,     8.  2.  1    |               Meaney J & Wehmeyer M (2005). Reducing health disparity
 469   II,     8.  2.  1    |     Jørgensen, F., & OFarrell, L., (2005). Brief Research Report
 470   II,     8.  2.  2    |             Ireland (Donnelly et al, 2005) and Italy (Nucci et al,
 471   II,     8.  2.  2    |              and Italy (Nucci et al, 2005). The results indicate a
 472   II,     8.  2.  2    |             Ireland (Donnelly et al, 2005) and Italy (Nucci et al,
 473   II,     8.  2.  2    |              and Italy (Nucci et al, 2005). The results indicate a
 474   II,     8.  2.  2    |         Stewart NM and Hollinger M. (2005): Prevalence and outcomes
 475   II,     8.  2.  2    |              Corsi A and Cerulli L. (2005): Incidence of visual loss
 476   II,     9            |               Clearly-Goldman et al, 2005; Luke and Brown, 2007a;
 477   II,     9            |           pregnancies (Ananth et al, 2005; Garite et al, 2004). Figures
 478   II,     9            |    Percentage of mothers under 20 in 2005 or most recent year~ ~Fi ~ ~
 479   II,     9            |              with ART (Hansen et al, 2005). Particularly stringent
 480   II,     9            |           living in poverty (UNICEF, 2005). Data on maternal education
 481   II,     9            |         mineral deficiency (Volkert, 2005). Obtaining adequate nutrition
 482   II,     9            |             in the elderly (Volkert, 2005). Healthy food and eating
 483   II,     9            |             active elderly (Volkert, 2005). The level of physical activity
 484   II,     9.  1.  1    |             and infant mortality for 2005 or most recent available
 485   II,     9.  1.  1    |       selected EUGLOREH countries in 2005 or most recent year~ ~Congenital
 486   II,     9.  1.  1(1) |              based on one year data (2005) and 25 deaths only.~
 487   II,     9.  1.  1    |           Demissie K, Vintzileos AM (2005): Trends in twin preterm
 488   II,     9.  1.  1    |       mortality. Am J Obstet Gynecol 2005;193(3 Pt 2):1076-82.~ ~Alexander
 489   II,     9.  1.  1    |              DA, Comstock CH, et al (2005): Impact of maternal age
 490   II,     9.  1.  1    |              outcome. Obstet Gynecol 2005;105(5 Pt 1):983-90.~Cnattingius
 491   II,     9.  1.  2    |               Clearly-Goldman et al, 2005; Luke and Brown, 2007a;
 492   II,     9.  1.  2    |           pregnancies (Ananth et al, 2005; Garite et al, 2004). Figures
 493   II,     9.  1.  2    |    Percentage of mothers under 20 in 2005 or most recent year~ ~Figure
 494   II,     9.  1.  2    |              with ART (Hansen et al, 2005). Particularly stringent
 495   II,     9.  1.  2    |       Abramsky et al, 2007; EUROCAT, 2005) and is the major primary
 496   II,     9.  1.  2    |              across Europe (EUROCAT, 2005). Screening policies vary
 497   II,     9.  1.  2    |         European countries (EUROCAT, 2005), and even countries with
 498   II,     9.  1.  2    |             implementation (EUROCAT, 2005).~ ~An increasing proportion
 499   II,     9.  1.  2    |            et al, 2004; Garne et al, 2005). Such variation may result
 500   II,     9.  1.  2    |      insufficient and short-term. In 2005, approximately 4 million